Changeflow GovPing Healthcare & Life Sciences MCI Intervention Study, 200 Older Adults, Apr 2...
Routine Notice Added Final

MCI Intervention Study, 200 Older Adults, Apr 23, 2026

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

This ClinicalTrials.gov registry entry documents NCT07549074, a double-blind, clustered, randomized, controlled four-arm parallel group study investigating a short-term multicomponent intervention to improve cognitive abilities in older adults with Mild Cognitive Impairment (MCI). The study will recruit 200 eligible older adults with MCI from local elderly centres and randomly allocate activity groups to multicomponent intervention, cognitive stimulation, lifestyle psychoeducation, or control in a 1:1:1:1 ratio; both participants and assessing investigators are blinded to group allocation. Outcomes will be assessed using standardized tools before and after the intervention and after 3 months.

“The research aims to investigate the effectiveness of a new short-term multicomponent intervention to promote the bio-psycho-social-spiritual health of older adults with MCI to improve their cognitive abilities.”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.

What changed

This ClinicalTrials.gov study record (NCT07549074) registers a new randomized controlled trial investigating a multicomponent intervention combining healthy lifestyle psychoeducation and cognitive stimulation for older adults with Mild Cognitive Impairment. The study employs a double-blind, clustered, four-arm parallel design with 200 participants randomly assigned to multicomponent intervention, cognitive stimulation, lifestyle psychoeducation, or control groups in equal proportions. Participant blinding and investigator blinding are both specified, with standardized outcome assessments scheduled at baseline, post-intervention, and 3-month follow-up. Healthcare researchers, clinical investigators, and sponsors conducting similar cognitive-intervention trials should ensure their protocols are similarly registered and that blinding procedures are documented to meet NIH transparency requirements.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Multicomponent Intervention to Improve Cognitive Abilities in Older Adults With Mild Cognitive Impairment

N/A NCT07549074 Kind: NA Apr 23, 2026

Abstract

The research aims to investigate the effectiveness of a new short-term multicomponent intervention to promote the bio-psycho-social-spiritual health of older adults with MCI to improve their cognitive abilities.

In this study, the multicomponent intervention consists of healthy lifestyle psychoeducation and cognitive stimulation. This study is a double-blind, clustered, randomized, controlled, four-arm parallel group study. 200 eligible older adults with MCI are openly recruited into activity groups in local elderly centres. The activity groups are randomly allocated to three intervention groups (i.e., multicomponent intervention, cognitive stimulation and lifestyle psychoeducation) and a control group in a 1:1:1:1 ratio. The participants with MCI are blinded on group allocation and kept uninformed which type of intervention they are receiving. An investigator, blinded to group allocation and intervention, assess outcomes using standardized assessment tools before and after the intervention and after 3 months.

Conditions: Mild Cognitive Impairment (MCI)

Interventions: Cognitive stimulation, Lifestyle psychoeducation, Sham cognitive stimulation, Sham Lifestyle Psychoeducation

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 23rd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Docket
NCT07549074

Who this affects

Applies to
Clinical investigators Healthcare providers Researchers
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Cognitive intervention research MCI treatment study
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Public Health Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!